Assessment of inflammatory markers in Acne vulgaris patients: serum IL-17, IL22, and IL-10
Article Sidebar
Main Article Content
Abstract
One of the four main factors in the pathophysiology of acne vulgaris (AV) is inflammation, which may be a primary or secondary process caused by Propionibacterium acnes. To counteract inflammatory mediators, the immune system possesses a variety of anti-inflammatory mechanisms. The data supporting the early involvement of the inflammatory pathway in the etiology of AV, a chronic, complex, inflammatory skin condition, has become more clear. This cell line's activators, Th17 cells, and the cytokines that follow are all probably important in initiating and maintaining the disease. The aim of this study is to determine the degree to which acne vulgaris is influenced by the interleukins IL-10, IL-17, and IL-22. Individualized patients in our study, sex-matched controls were included, and there were 42 male and 58 female AV patients, aged 12 to 30. An enzyme-linked immunosorbent assay (ELISA) was used to measure the serum levels of IL-10, IL-17, and IL-22. The levels were then connected with the severity of acne. In cases, the serum levels of IL-10, IL-17, and IL-22 were 0.34±0.080, 0.13, 0.14±0.0035, 0.136-0.233, and 0.24±0.0142, 0.126-0.243 pg/ml, respectively, while in controls, they were 0.13±0.028, 0.10±0.0085, 0.14±0.0035, 0.117-0.126, and 0.22±0.0089, 0.114-0.127 pg/ml. For IL-10 and IL-17, there was a substantial difference in levels between patients and controls; however, for IL-22, the difference was negligible. The levels of IL-10 and IL-17 showed an extremely strong positive connection. This study came to the conclusion that IL-10 and IL-17 are important effectors in the pathophysiology of AV. In acne lesions, Th17 cells activated by IL-22 are probably the main source of IL-37.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Williams, H. C., Dellavalle, R. P., & Garner, S. (2012). Acne vulgaris. The Lancet, 379(9813), 361-372.
2. Younis, S., & Javed, Q. (2015). Theinterleukin-6 and interleukin-1A gene promoter polymorphism is associated with the pathogenesis of acne vulgaris. Archives of dermatological research, 307 (4), 365-370.
Karadag, A. S., Ertugrul, D. T., Bilgili, S. G., Takci, Z., Akin, K. O., & Calka, O. (2012). Immunoregulatory effects of isotretinoin in patients with acne. British Journal of Dermatology, 167(2), 433-435.
Dreno, B., Poli, F., Pawin, H., Beylot, C., Faure, M., Chivot, M., ... &Revuz, J. (2011). Development and evaluation of a Global Acne Severity scale (GEA scale) suitable for France and Europe. Journal of the European Academy of Dermatology and Venereology, 25(1), 43-48.
Slayden, S. M., Moran, C., Sams Jr, W. M., Boots, L. R., & Azziz, R. (2001). Hyperandrogenemia in patients presenting with acne. Fertility and sterility, 75(5), 889-892.
Rahman, M. M., Sikder, M. A. U., Rashid, M. M., Khondker, L., Hazra, S. C., & Nessa, M. (2012). Association of serum testosterone with acne vulgaris in women. Bangabandhu Sheikh Mujib Medical University Journal, 5(1),1-5.
Beutler, B. (Ed.). (1992). Tumor necrosis factors: the molecules and their emerging role in medicine (Vol. 925). Lippincott Williams & Wilkins.
Dinarello, C. A. (1996). Biologic basis for interleukin-1 in disease. Blood, 87(6), 2095-2147.
9. Guy R, Kealey T. (2006). The effects of inflammatory cytokines on the isolated human sebaceous infundibulum. J Invest Dermatol. 110: 410–5.
10. Kawaguchi, Y., Tochimoto, A., Hara, M., Kawamoto, M., Sugiura, T., Saito, S., & Kamatani, N. (2007). Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1αand its transcription activity. Immunogenetics, 59(6), 441-448.
Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., & De Vries, J. (1992). Biological propertiesof interleukin 10. Journal of clinical immunology, 12(4), 239-247.
Rasool, L. M. (2017). Study of bacterial causative agents of acne and the effect of some antibiotics onthem. Al-Fatih journal, 13(72), 60-69.
Nada, E. A. A. (2012). Tissue liver x-receptor alpha (LXRα) level in acne vulgaris.
White, A. (2015). The Effects of a Low Glycemic Load Diet on Acne Vulgaris in Adolescents and Young Adults.
Elhannan, S., Taha, S., Ben Khalaf, N., Bakheit, H., Fathallah, M. D., & Bakhiet, M. (2015). Induction of dissociated cytokine profiles by ISRAA with selective critical involvement of ERK1/2 in its signaling functions. International journal of molecular medicine, 36(6), 1583-1592.
Ingham, E., Eady, E. A., Goodwin, C. E., Cove, J. H., & Cunliffe, W.J. (1992). Pro-Inflammatory Levels of Interleukin-1α-Like Bioactivity Are Present in the Majority of Open Comedones in Acne Vulgaris.Journalofinvestigativedermatology,98(6),895-901.
Jeremy, A. H., Holland, D. B., Roberts, S. G., Thomson, K. F., & Cunliffe, W. J. (2003). Inflammatory events are involved in acne lesion initiation. Journal of Investigative Dermatology, 121(1), 20-27.
Defrance, T., Vanbervliet, B., Briere, F., Durand, I., Rousset, F., & Banchereau, J. (1992). Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. Journal of Experimental Medicine, 175(3), 671-682.
Itoh, K., & Hirohata, S. (1995). The role of IL-10 in human B cell activation, proliferation, and differentiation. The Journal of Immunology, 154(9), 4341-4350.
Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., & Romagnani, S. (1993). Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. The Journal of Immunology, 150(2), 353-360.
Igietseme, J. U., Ananaba, G. A., Bolier, J., Bowers, S., Moore, T., Belay, T., ... & Black, C. M. (2000). Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. The journal of immunology,164(8),4212-4219.
de Lafaille, M. A. C., & Lafaille, J. J. (2002). CD4+ regulatory T cells in autoimmunity and allergy. Currentopinion inimmunology, 14(6),771-778.
Levings, M. K., Bacchetta, R., Schulz, U., & Roncarolo, M. G. (2002). The role of IL-10 and TGF-β in the differentiation and effector function of T regulatory cells. International archives of allergy and immunology, 129(4), 263-276.